Mental Health DailyResearch. Evidence. Perspective.Published research on levetiracetam.
In a 2026 case report from China, a 34-year-old woman with mild intellectual disability was sent for evaluation of possible narcolepsy. Sleep testing and EEG instead showed epilepsy and mode…
Read articleA 2026 CNS Drugs review argues that seletracetam, an abandoned second-generation racetam antiseizure drug, may be unusually well suited for seizure rescue: early oral studies involved 171 pa…
Read articleA 2026 real-world study involving 1,174 children with epilepsy proposed a levetiracetam therapeutic drug monitoring range of 2.82-24.37 mcg/mL, much lower than commonly cited adult-style ran…
Read articleA 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke was associated with 53 vs. 62 deaths per 1,000 over 90 days, a risk difference of −9 deaths p…
Read article
